Obesity and chronic kidney disease

Nefrologia

Volumn 31, Issue 4, 2011, Pages 397-403

  Eknoyan, Garabed ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Albuminuria; Diabetes; Hypertension; Kidney disease; Obesity

Indexed keywords

CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE COURSE; EPIDEMIOLOGY; FOLLOW UP; HUMAN; HYPERTENSION; INSULIN RESISTANCE; KIDNEY; KIDNEY CIRCULATION; KIDNEY DISEASE; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; PROTEINURIA; RENAL REPLACEMENT THERAPY; RISK FACTOR; SHORT SURVEY; WEIGHT REDUCTION;

CARDIOVASCULAR DISEASES; CHRONIC DISEASE; CONFOUNDING FACTORS (EPIDEMIOLOGY); CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INSULIN RESISTANCE; KIDNEY; KIDNEY DISEASES; OBESITY; PROGNOSIS; PROTEINURIA; RENAL CIRCULATION; RENAL DIALYSIS; RISK FACTORS; WEIGHT LOSS;

EID: 79961117762     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2011.May.10963     Document Type: Short Survey

References (65)

1. Eknoyan G. A history of obesity, or how what was good became ugly and then bad. Adv Chronic Kidney Dis 2006;13:421-7.
2. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. J Am Medical Assoc 2002;288:1723-7.
3. Pi-Sunyer X. The medical risks of obesity. Postgrad Med 2009;121:21-33.
4. Yanovski SZ, Yanovski JA. Obesity prevalence in the United States-Up, down, or sideways. N Engl J Med 2011;364:987-9.
5. Kopelman P. Health risks associated with overweight and obesity. Obesity Rev 2007;8(Suppl 1):13-7.
6. Eknoyan G. Obesity, diabetes, and chronic kidney disease. Curr Diabetes Rep 2007;7:449-53.
7. Pan SY, DesMeules M, Morrison H, Wen SW. Obesity, high energy intake, lack of physical activity, and the risk of kidney cancer. Cancer Epid Biom Prev 2006;15:2453-60.
8. Praga M. Obesity-a neglected culprit in renal disease. Nephrol Dial Transpl 2002;17:1157-9.
9. Sivestava T. Nondiabetic consequences of obesity on kidney. Pediatr Nephrol 2006;21:463-70.
10. Rutkowski P, Klasen A, Sebekova K. Renal disease in obesity. The need for greater attention. J Ren Nutr 2006;16:216-33.
11. Chertow GM, Hsu C, Johansen KL. The emerging body of evidence: obesity and chronic kidney disease. J Am Soc Nephrol 2006;17:1501-2.
12. Mathew AV, Okada S, Sharma K. Obesity related kidney disease. Curr Diabetes Rev 2011;7:41-9.
13. Preble WE. Obesity: observations on one thousand cases. Boston Med Surg J 1923;188:617-21.
14. Wang Y, Chen X, Song Y, Caballero B, Cheskin LJ. Association between obesity and kidney disease. A systematic review and metaanalysis. Kidney Int 2008;73:19-33.
15. O'Donnell MP, Kasiske BL, Cleary MP, Keane WF. Effects of genetic obesity on renal status and function in the Zucker rat. J Lab Clin Med 1985;106:605-10.
16. Henegan JR, Bigler SA, Henegan LK. Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 2001;12:1211-7.
17. Maddox DA, Alavi FK, Santella RN, Zawada ET. Prevention of obesity-linked renal disease: age dependent effect of dietary food restriction. Kidney Int 2002;62:208-19.
18. Rea DJ, Heinbach JK, Grande JP, Textor SC, Taler SJ. Prieto M, et al. Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney Int 2006;70:1636-41.
19. Valensi P, Assayag M, Busby M, Pariès J, Lormeau B, Attali. JR, et al. Microalbuminuria in obese patients with or without hypertension. Int J Obesity 1996;20:574-9.
20. Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J. Gafter U. Glomerular hemodynamic in severe obesity. Am J Physiol Renal Physiol 2000;278:F817-F822.
21. Praga M, Hernández F, Andrés A. Effects of body weight loss and captopril treatment on proteinuria associated with obesity. Nephron 1995;70:34-41.
22. Blanco S, Bonet J, López D, Casas I, Romero R. ACE inhibitors improve nephrin expression in Zucker rats with glomerulosclerosis. Kidney Int 2005;(Suppl):S10-S14.
23. Esler M, Rumanti M, Weisner G. Sympathetic nervous system and insulin resistance: from obesity to diabetes. Am J Hypertens 2001;14(Suppl 1):304s-309s.
24. Hall JE, Kuo JJ, Silva AA, De Paula RB, Liu J, Tallam L. Obesityassociated hypertension and kidney disease. Curr Opin Nephrol Hypertens 2003;12:195-200.
25. Savage S, Nagel NJ, Estacio RO, Lukken N, Schrier RW. Clinical factors associated with urinary albumin excretion in Type II diabetes. Am J Kidney Dis 1995;25:836-44.
26. DeJong PE, Verhave JC, Pinto-Sietsma SJ, Hillege HL. PREVEND Study Group: Obesity and target organ damage: the kidney. Int J Obesity 2002;26(Suppl 4):S21-S24.
27. Kohler KA, McClellan WM, Ziemer DC, Kleinbaum DG, Boring JR. Risk factors for microalbuminuria in black Americans with newly diagnosed type 2 diabetes. Am J Kidney Dis 2000;36:903-13.
28. Toto RD, Greene T, Hebert LA. Relationship of body mass index and proteinuria in hypertensive nephrosclerosis: results from the African American Study of Kidney Disease and Hypertension (AASK) cohort. Am J Kidney Dis 2010;56:896-906.
29. Morales E, Valero MA, León M, Hernández E, Praga M. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 2003;41:319-27.
30. Praga M, Morales E. Obesity-related renal damage: changing diet to avoid progression. Kidney Int 2010;78:633-5.
31. Afshinnia F, Wilt TJ, Duval S, Esmaeili A. Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. Nephrol Dial Transpl 2010;25:1173-83.
32. Poggio ED, Nef PC, Wang X, Greene T, Van Lente F, Dennis VW, et al. Performance of the Cockcroft-Gault and Modification of Diet in Renal Disease equations estimating GFR in ill hospitalized patients. Am J Kidney Dis 2005;46:242-52.
33. Friedman AN, Strother M, Quinney SK. Measuring of glomerular filtration rate in obese individuals without overt kidney disease. Nephron Clin Pract 2010;116:c224-c234.
34. Ritz E, Koleganova N, Piecha G. Is there an obesity-metabolic related glomerulopathy? Curr Opin Nephrol Hypert 2011;20:44-9.
35. Cohen AH. Massive obesity and the kidney: a morphologic and statistical study. Am J Pathol 1975;81:117-30.
36. Kamlan N, Markowitz GS, Valeri AM. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001;51:1498-1509.
37. Weisinger JR, Kempon RL, Eldridge FL. The nephrotic syndrome: a complication of massive obesity. Ann Intern Med 1974;81:440-7.
38. Wesson DE, Kurtzman NA, Frommer JP. Massive obesity and nephrotic proteinuria with a normal renal biopsy. Nephron 1985;40:235-7.
39. Izzedine H, Coupage M, Reach I. Gastric bypass and resolution of proteinuria in an obese diabetic patient. Diab Med 2005;22:1761-2.
40. Perez G, Devaud N, Escalora A, Downey P. Resolution of early stage diabetic nephropathy in an obese diabetic after gastric bypass. Obes Surg 2006;16:1388-91.
41. Goumeros DS, Kawar B, El Nahas M. Early histologic changes in the kidney of people with morbid obesity. Nephrol Dial Transpl 2009;24:3732-8.
42. Praga M, Hernández E, Morales E, Pérez A, Valero MA, Martínez MA, et al. Clinical features and long-term outcome of obesity associated focal segmental glomerulosclerosis. Nephrol Dial Transpl 2001;16:1790-8.
43. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PWF, Levy D. Prediction of new-onset kidney disease in a community-based hospital. J Am Med Assoc 2004;291:844-50.
44. Iseki K, Ikenuya Y, Kinjo K. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004;65:1870-9.
45. Hsu C, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006;144:21-8.
46. Sjerblad E, Fored CM, Lindbald P. Obesity and risk for chronic renal failure. J Am Soc Nephrol 2006;17:1695-702.
47. Bonnet F, Deprele C, Sassolas A, Moulin P, Alamartine E, Berthezene F, et al. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis 2001;37:720-7.
48. Praga M, Hernandez E, Herrero JC, Morales E, Revilla Y. Díaz-González R, et al. Influence of obesity on appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int 2000;58:2111-8.
49. Meier-Kriesche H, Andorfer JA, Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation 2002;73:70-4.
50. Kramer H, Luke A. Obesity and kidney disease: a big dilemma. Curr Opin Nephrol Hypertens 2007;16:237-41.
51. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005;81:543-54.
52. DeMutsert R, Snijder MB, Van der Sman-deBeer F. Association of body mass index and mortality is similar in the hemodialysis population at high age and equal duration of follow-up. J Am Soc Nephrol 2007;18:967-74.
53. Wolf G. After all those fat years: renal consequences of obesity. Nephrol Dial Transplant 2003;18:2471-4.
54. Druml W, Metnitz B, Schaden E, Bauer P, Metnitz PG. Impact of body mass on incidence and prognosis of acute kidney injury requiring renal replacement therapy. Int Care Med 2010;36:1221-8.
55. Chudek J, Adamczak M, Nieszporek T. The adipose tissue as a source of vasoactive hormones and cytokines with a potential role in the pathogenesis of cardiovascular and renal diseases. Rev Port Nephrol Hypert 2006;20:81-91.
56. Carlyle M, Jones OB, Kuo JJ, Hall JE. Chronic cardiovascular and renal actions of leptin role in adrenergic activity. Hypertension 2002;39:496-501.
57. Wolf G, Hamann A, Han DC, Helmchen U, Thaiss F, Ziyadeh FN, et al. Leptin stimulates proliferation and TGF-α expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int 1999;56:860-72.
58. Sarafadis PA, Ruilope LM. Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol 2006;26:232-44.
59. Hunley TE, Ma L, Kon V. Scope and mechanism of obesity-related renal disease. Curr Opin Nephrol Hypert 2010;19:227-34.
60. Ix JH, Sharma K. Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: The roles of fetuin-A, adenopectin, and AMPK. J Am Soc Nephrol 2010;21:406-12.
61. Tesauro M, Canale MP, Rodia G. Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines. Cardio Res Pract 2011;Article ID 653182.
62. Teplan V Jr, Vyhnanek F, Guerlich R. Increased proinflammatory cytokine production in adipose tissue of obese patients with chronic kidney disease. Wien Klin Wochenschr 2010;122:466-73.
63. Ruggiero C, Ehrenshaft M, Cleland E, et al. High fat diet induces an initial adaptation f mitochondrial bioenergetics in the kidney despite evident oxidative stress and mitochondrial ROS production. Am J Physiol Edocrinol Metab 2011;Mar 8 [Epub ahead of print].
64. Kanauchi M. Comparison of renal histology between Japanese obese and non-obese microalbuminuric type 2 diabetic patients. Nephrol Dial Transpl 2003;18:849-50.
65. Wesson DE, Simoni J. Acid retention during kidney failure induces endothelin and aldosterone which lead to progressive GFR decline, a situation ameliorated by alkali diet. Kidney Int 2010;78:1128-35.